previous
next
close
quote
twitter
facebook
linkedin
instagram
Home
Speakers
Digital Platform
Partnership
Agenda
Blog
Register
Contact
Industry Insights: Anthony Schwartz, Morphiex Biotherapeutics
Anthony Schwartz, CEO, Morphiex Therapeutics, shares his thoughts on the leading challenges when targeting the CD47/SIRPa axis.
Click here to download your copy
Recent News
Hopin FAQs
Read more +
Industry Insights: Taylor Schreiber, Shattuck Labs
Read more +
Industry Insights: Kipp Weiskopf, Whitehead Institute
Read more +